NCT00773292View on ClinicalTrials.gov

Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions

HTLV I Associated Myelopathy

Interventions

DRUG

ciclosporin

Ciclosporin 2.5 - 5mg/kg/day in two equally divided doses. dose adjusted according to trough ciclosporin concentration

Trial Locations (1)

W2 1NY

National Centre for Human Retrovirology, London

Sponsors

Collaborators (1)

Medical Research Council

All Listed Sponsors

collaborator

Medical Research Council

OTHER_GOV

collaborator

University Hospital Birmingham

OTHER

collaborator

Imperial College Healthcare NHS Trust

OTHER

lead

Imperial College London

OTHER